PODCAST · business
LifeSci Beat
by Wharton Health Care
LifeSci Beat is a Wharton MBA student-run podcast dedicated to exploring the business of innovation in the life sciences. We are focused on chronicling the latest discoveries in life sciences (biotech, medtech, diagnostics, and more) and uncovering the business challenges faced by leaders in bringing cutting edge technology to market.
Episodes
-
Dr. James Min, Founder & CEO of Cleerly Health, on Building a Cardiology Care Management Platform
In the third episode of Season 3, we spoke with Dr. James Min, Founder and CEO of Cleerly Health, about his experience turning his clinical research into Cleerly and how he’s managed the business as the treatment of coronary artery disease evolves thanks to new research, new technology like...
-
Dr. Barthalomew (B.A.) Sillah, COO of Avesta76 Therapeutics, on Company Creation and Driving Inclusion in Biotech
In the second episode of Season 3, we spoke with Dr. Barthalomew Sillah, COO of Avesta76 therapeutics about his experiences turning innovative science into impactful therapeutics. Our conversation touched on being open-minded to new opportunities, learning from non-biotech experiences in the...
-
Eshwar Inapuri, Former CEO & Co-Founder of InnaMed, on Founding Diagnostics Companies
In the first episode of Season 3 of LifeSci Beat, we chatted with Eshwar Inapuri, Former CEO & Co-Founder of InnaMed. Our conversation spanned diagnostics company creation, navigating challenges as a young entrepreneur, and new frontiers and trends in the diagnostics space. InnaMed is an at-home...
-
James Mutamba, CBO of Arrakis Therapeutics, on Biotech BD and IPO financing
In this episode, we chatted with Dr. James Mutamba, CBO of Arrakis Therapeutics. Our conversation covered biotech IPO financing, the process of business development dealmaking, company creation, and the Arrakis Therapeutics platform. Arrakis Therapeutics is an preclinical private biotech…
more -
Oriana Papin-Zoghbi on Revolutionizing Early-stage Ovarian Cancer Diagnosis
In this ninth episode, we spoke with Oriana Papin-Zoghbi, co-founder and CEO of AOA Dx. We discussed her global upbringing and early career, the current standard of ovarian cancer diagnosis, and building a company from academic research.
-
Alex Sapir, Former CEO of ReViral Ltd. and Dova Pharmaceuticals, on Advancing Pipeline Candidates and Financing Biotech Companies
In the eighth episode of this season, we chatted with Alex Sapir about his various experiences leading life sciences companies through commercial launches and key funding milestones. We spoke about his career beginnings at GSK, ZS Associates, and United Therapeutics. Additionally, we covered his...
-
Geoff Meyerson, CEO & Co-Founder of Locust Walk, on Building a Global Biotech Advisory Firm
In this episode, we sat down with Geoff Meyerson — CEO & Co-Founder at Locust Walk. We discuss Geoff’s extensive life science career, which includes stints in investment banking, venture capital, and business development. We also dive into the founding story and journey of Locust Walk, a global...
-
Dr. Pitou Devgon, Co-Founder of Velano Vascular, on Creating Value in a Commoditized Device Market
In the sixth episode of our second season, we sat down with Dr. Pitamber "Pitou" Devgon, co-founder of Velano Vascular, active angel investor, and Lecturer at the Wharton School of Business. We discussed the origins of Velano Vascular’s central PIVO™ technology, the importance of collecting...
-
Imogen Pryce, COO of R&D at Relay Therapeutics, on the Dynamo Platform and Portfolio Strategy
In this episode, we chatted with Dr. Imogen Pryce, COO of R&D at Relay Therapeutics. Our conversation covered Relay Therapeutics’ scientific strategy, its unique Dynamo™ platform, and its underlying commercialization strategy and scientific differentiation. Relay Therapeutics (Nasdaq: RLAY) is a...
-
Rami Elghandour, Chairman & CEO of Arcellx, on Building Great Teams & Cultures
In the fourth episode of our second season, we spoke with Rami Elghandour, Chairman & CEO of Arcellx. Our conversation focused on the importance of building a company's culture from day one and how firms can turn their cultures into a competitive advantage. Arcellx is a clinical stage biotech...
-
Ankit Mahadevia, CEO of Spero Therapeutics, on Leadership in Biotechnology and Innovation in Antibiotic Development
In the third episode of our second season, we spoke with Dr. Ankit Mahadevia, CEO of Spero Therapeutics and former Venture Partner at Atlas Venture. Our conversation focused on the benefits of diverse exposure within the healthcare ecosystem, unique challenges of developing antibiotics, and...
-
Leo Grady Ph.D. on Leveraging AI to Impact Healthcare
On the second episode of this season, we chatted with Leo Grady Ph.D. Our conversation focused on his career working at medical technology companies and the many applications of AI in healthcare. Leo is internationally recognized for his work to deliver AI in healthcare for 20 years at the...
-
Kiersten Stead, Managing Partner at DCVC Bio, on Deep TechBio Company Creation
In the first episode of our second season, we chatted with Dr. Kiersten Stead, Managing Partner at DCVC Bio. Our conversation focused on computational drug discovery, her latest investments, and the keys to company creation in this burgeoning space. DCVC Bio is the bio-focused arm of DCVC, a VC...
-
John Evans, CEO of Beam Therapeutics, on the Business of Biotech
In our final episode of our first season, we chatted with John Evans, CEO of Beam Therapeutics. Our conversation spans lessons in commercializing therapies across the development life cycle, programmable gene editing platforms, evaluating biopharma partnerships, future trends in gene therapy...
-
Brian Harris, CEO and Co-Founder of MedRhythms, on Pioneering the Next Generation of Digital Therapeutics Using Music to Improve Walking
In this episode, we spoke with Brian Harris, CEO and Co-Founder of MedRhythms. We explore Brian’s upbringing and how his passion for music and desire to help people manifested into the career he has today. We dive into his career as a music therapist which led to the creation of MedRhythms....
-
Enoch Kariuki, Former CEO of Lengo Therapeutics, on Translating Science to Therapies
In this episode, we sat down with Dr. Enoch Kariuki – former CEO at Lengo Therapeutics, CFO at VelosBio, and SVP of Corporate Development at Synthorx. We explore Enoch’s upbringing in Kenya and how a family member’s battle with HIV inspired his pursuit of a career in healthcare. We also dive into...
-
Lalo Flores, CEO at Century Therapeutics, on Developing Next-Generation Cell Therapies
In this episode, we sat down with Dr. Osvaldo (Lalo) Flores, CEO at Century Therapeutics. We discuss Lalo's early career in R&D, the founding story (and eventual acquisition) of Novira Therapeutics, and his outlook on next-generation cell therapies with Century. Century Therapeutics is a...
-
Dr. Ali Behbahani, Partner at NEA, on evaluating and investing in cutting-edge life sciences
In this episode, we sat down with Dr. Ali Behbahani, General Partner at New Enterprise Associates. Dr. Behbahani has been with NEA since 2007, spearheading over 40 biotech and medtech investments such as CRISPR Therapeutics, Adaptimmune, and Nevro. We discussed his views on breaking into VC, his...
-
Karun Naga, Partner at The Foundry, on Creating Medical Technologies and Building Innovative Companies
In this episode, we sat down with Karun Naga, Partner at The Foundry, a leading venture studio focused on building pioneering life-saving medical technologies. We discuss the business model of The Foundry, Karun's early career journey that led him to medical device start-ups, his successful...
-
Molly Gibson, Co-Founder of Generate Biomedicines, on Innovating at the Intersection of AI/ML and Biotech
In this episode, we chatted with Molly Gibson, Co-Founder of Generate Biomedicines, a biotech that uses AI/ML to generate protein medicines and recently closed a $370M Series B financing. We discussed the key trends in computationally-powered drug discovery and bioplatforms, what it takes to...
-
Jamil Beg, Partner at 5AM Ventures, on Building and Investing in Innovative Biotech Companies
In this episode, we sat down with Jamil Beg, Partner at 5AM Ventures, a leading venture capital firm focused on building next-generation life science companies. We discuss Jamil's career journey, the challenges in scaling early-stage biotech companies, the current life science investing…
more -
Welcome to LifeSci Beat!
Welcome to our introductory episode of the LifeSci Beat. Here, we briefly cover our goals and motivation for the podcast and introduce our hosts: Shubham Chatterjee, Jaclyn Kawwas, and Kevin Nguyen. Stay tuned for our first interview, coming soon!
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
LifeSci Beat is a Wharton MBA student-run podcast dedicated to exploring the business of innovation in the life sciences. We are focused on chronicling the latest discoveries in life sciences (biotech, medtech, diagnostics, and more) and uncovering the business challenges faced by leaders in bringing cutting edge technology to market.
HOSTED BY
Wharton Health Care
Loading similar podcasts...